Lojaimiess Kit
Product Images NDC 70700-124

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lojaimiess (NDC 70700-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lojaimiess Blister

LoJaimiess kit containing levonorgestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP, with strengths of 0.1 mg/0.02 mg, and 0.01 mg. The label shows an extended-cycle tablet dispenser organized by weeks and days of the week for a total of 91 tablets. The labeler is Xiromed, LLC, and includes the NDC 70700-124.*

FDA Label Image

Lojaimiess Carton

Packaging label for LoJaimiess tablets KIT containing levonorgestrel and ethinyl estradiol tablets USP and ethinyl estradiol tablets USP, 0.1 mg/0.02 mg and 0.01 mg. The label specifies one extended-cycle tablet dispenser with 91 tablets, including 84 orange and 7 yellow tablets. Manufactured by Xiromed, LLC, the package also notes product origin from Spain.*

FDA Label Image

Lojaimiess Levonorgestrel

Chemical structure of levonorgestrel, showing the molecular formula C21H28O2 and a molecular weight of 312.4.*

FDA Label Image

Lojeimeiss Bar Chart

A vertical bar chart displaying the percentage of bleeding and/or spotting versus bleeding alone over four treatment cycles, each divided into periods of 7 or more days and 20 or more days. The x-axis lists Cycle 1 to Cycle 4 with corresponding days and sample sizes, while the y-axis shows percentages up to 80%. Bars are segmented to differentiate bleeding and bleeding with spotting, highlighting a decreasing trend across cycles.*

FDA Label Image

Lojeimeiss Chart

A diagram illustrating pregnancy rates per 100 women in one year with various birth control methods. The vertical axis ranges from 'fewer pregnancy' at the top to 'more pregnancy' at the bottom. Methods listed from lowest to highest pregnancy rates include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Lojeimeiss Effect Estimate

A horizontal forest plot comparing effect estimates from multiple studies on contraceptive use. The plot shows odds ratios (OR) and risk ratios (RR) with confidence intervals for studies including Ever COC vs. Never COC Use and Current COC Use vs. Never-Use, with a central vertical line at an effect estimate of 1.00.*

FDA Label Image

Lojeimeiss Ethinyl Estradiol

Chemical structure of ethinyl estradiol, showing its molecular formula C20H24O2 and a molecular weight of 296.4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.